Impact of Blood Storage Duration on Physiologic Measures



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:2/3/2017
Start Date:January 2011
End Date:January 2014

Use our guide to learn which trials are right for you!

Impact of Blood Storage Duration on Physiologic Measures: RECESS Ancillary Physiologic Study (RECAP)

This study is an ancillary (add-on) study to the clinical trial entitled Red Cell Storage
Duration Study (RECESS), which has clinicaltrials.gov identifier NCT00991341. The RECESS
study randomizes cardiac surgery patients to receive either red blood cell units stored for
no more than 10 days, or red blood cell units stored for at least 21 days, if they need any
red blood cell transfusions during their hospital stay for the surgery.

This ancillary study is entitled Impact of Blood Storage Duration on Physiologic Measures:
RECESS Ancillary Physiologic Study (RECAP). The hypothesis of the RECAP study is that there
will be differences between the two randomized treatment groups in how much the following
measurements change, from shortly before a red blood cell transfusion to shortly after a red
blood cell transfusion, and from before surgery to 24 hours after surgery:

- Oxygen saturation in the hand

- Oxygen saturation in the brain

- Blood flow in the small blood vessels under the tongue.

The RECAP study will also investigate whether changes in the measurements listed above are
associated with clinical outcomes, including

- The Multi-Organ Dysfunction Score

- Death from any cause

- Major cardiac events

- Major pulmonary events


Inclusion Criteria:

- Eligible and randomized in the RECESS study (NCT00991341)

- At least 18 years old

- Willing to comply with protocol and provide written informed consent for both RECESS
and RECAP

- Scheduled to undergo coronary artery bypass (CABG), valve, or combined CABG plus
valve surgery

Exclusion Criteria:

- Prior randomization into the RECESS or RECAP studies

- Undergoing off-pump cardiac surgery

- Undergoing a significant concomitant surgical procedure

- Known sickle cell disease

- Participation in a clinical trial (except observational studies or RECESS) within the
previous 30 days

- Received any investigational product within prior 30 days

- Not able to be randomized in RECESS
We found this trial at
4
sites
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
?
mi
from
Boston, MA
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
(612) 625-5000
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials